Radioactive therapy with 131 I (RAI) is commonly used during the management of patients
with differentiated thyroid cancer (DTC). The aim of this study was to determine the clinical …

Objective The purpose of the present study was to evaluate the clinical usefulness of the
delayed post-therapeutic 131 I scan in patients with well-differentiated thyroid cancer by …

Background The aim was to compare the detect ability of three sequential 131I whole-body
scans (tri-WBS) on the second, third, and fourth day after 131I therapy for metastatic thyroid …

Objective: The purpose of this study is to compare early (3 days after administration) and
delayed (7–9 days after administration) post-therapeutic 131 I scanning for detecting …

Posttherapy scans (PTS) with a gamma camera are typically used after therapeutic doses of
131I to visualize metastases that may not be seen with lower dose diagnostic scans. During …

Objective The aim of this study was to investigate the appropriate time for performing an
iodine-131 post-therapy whole-body scan (TxWBS) through a qualitative and …

Objective This study aims to determine whether a 131 I double-phase whole body scan
(WBS) and SPECT-CT images have added value over a single-phase WBS image in …

Purpose The purpose of this study is to compare post-therapy third day and seventh day I-
131 whole body scans (3DWBS and 7DWBS) in detecting lung or bone metastasis from well …

Results During mean follow-up of 13.7±4.2 years, 20% of patients developed recurrence. At
the end of follow-up, 21% of patients had persistent disease. The clinical and histological …

Abstract Background Iodine-131 (I-131) whole-body scan (WBS) plays an important role in
the management of patients with differentiated thyroid carcinoma (DTC), to detect normal …